Literature DB >> 29307290

Multiple sclerosis genetics.

Ester Canto1, Jorge R Oksenberg1.   

Abstract

A broad scientific consensus has emerged linking multiple sclerosis (MS) risk to multiple independent and interacting DNA variants that are relatively frequent in the population and act in concert with environmental exposures. The multifactorial, polygenic model of heritability provided the rationale and impetus to pursue genome-wide association studies (GWAS), which have been highly successful in uncovering genetic variants influencing susceptibility. Over 200 loci have been firmly associated with MS susceptibility. The main association signal genome-wide maps to the major histocompatibility complex ( MHC) gene cluster in chromosome 6p21. This association has been observed across all populations studied. However, a significant proportion of MS heritability remains unexplained. Decoding the genetics of MS represents a long-standing and important research goal in this disease, as the demonstration of even modest functional genomic effects on risk or the course of MS is likely to reveal fundamental disease mechanisms and possibly yield new therapeutic opportunities.

Entities:  

Keywords:  Genome-wide association study; HLA

Mesh:

Year:  2018        PMID: 29307290     DOI: 10.1177/1352458517737371

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  16 in total

1.  The immune signatures of multiple sclerosis: Lessons from twin studies.

Authors:  Pablo Villoslada; Scott S Zamvil
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-14       Impact factor: 11.205

2.  Loading Rate of Exogenous and Autoantigenic Determinants on Major Histocompatibility Complex Class II Mediates Resistance to Multiple Sclerosis.

Authors:  A E Mamedov; M Yu Zakharova; O O Favorova; O G Kulakova; A N Boyko; V D Knorre; N A Vorobieva; E N Khurs; I S Kiselev; N M Baulina; A G Gabibov; A A Belogurov
Journal:  Dokl Biochem Biophys       Date:  2019-06-14       Impact factor: 0.788

3.  Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population.

Authors:  Eda Sezer; Birsen Can Demirdöğen; Şeref Demirkaya; Giray Bulut; Merve Akkulak; Emre Evin; Orhan Adalı
Journal:  Neurol Sci       Date:  2021-09-21       Impact factor: 3.307

Review 4.  The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.

Authors:  Caterina Veroni; Francesca Aloisi
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

Review 5.  Vitamin D as a Potential Therapy for Multiple Sclerosis: Where Are We?

Authors:  Samiksha Wasnik; Isha Sharma; David J Baylink; Xiaolei Tang
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

6.  Gene variants of adhesion molecules predispose to MS: A case-control study.

Authors:  Efthimios Dardiotis; Elena Panayiotou; Vasileios Siokas; Athina-Maria Aloizou; Kyproula Christodoulou; Andreas Hadjisavvas; Marios Pantzaris; Nikolaos Grigoriadis; Georgios M Hadjigeorgiou; Theodoros Kyriakides
Journal:  Neurol Genet       Date:  2019-01-16

7.  Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase.

Authors:  Zbyšek Pavelek; Francesco Angelucci; Ondřej Souček; Jan Krejsek; Lukáš Sobíšek; Blanka Klímová; Jana Šarláková; Simona Halúsková; Kamil Kuča; Martin Vališ
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

8.  N-Glycan Branching Decouples B Cell Innate and Adaptive Immunity to Control Inflammatory Demyelination.

Authors:  Christie-Lynn Mortales; Sung-Uk Lee; Armen Manousadjian; Ken L Hayama; Michael Demetriou
Journal:  iScience       Date:  2020-07-18

9.  Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides.

Authors:  Azad Mamedov; Nadezhda Vorobyeva; Ioanna Filimonova; Maria Zakharova; Ivan Kiselev; Vitalina Bashinskaya; Natalia Baulina; Alexey Boyko; Alexander Favorov; Olga Kulakova; Rustam Ziganshin; Ivan Smirnov; Alina Poroshina; Igor Shilovskiy; Musa Khaitov; Yuri Sykulev; Olga Favorova; Valentin Vlassov; Alexander Gabibov; Alexey Belogurov
Journal:  Front Immunol       Date:  2020-01-17       Impact factor: 7.561

10.  Multiple Sclerosis: Shall We Target CD33?

Authors:  Vasileios Siokas; Zisis Tsouris; Athina-Maria Aloizou; Christos Bakirtzis; Ioannis Liampas; Georgios Koutsis; Maria Anagnostouli; Dimitrios P Bogdanos; Nikolaos Grigoriadis; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  Genes (Basel)       Date:  2020-11-12       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.